Skip to main content

JANE STREET GROUP, LLC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1595888 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$7,838,003 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
19 quarters on record

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Derivatives in SNDX

reported options exposure · as of Jun 30, 2026
CallValue
$430,642
CallShares
19,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $430,642 19,700
2026-03-31 $7,838,003 335,531
2026-03-31 $777,888 33,300
2026-03-31 $378,432 16,200
2025-12-31 $699,633 33,300
2025-12-31 $979,066 46,600
2025-12-31 $15,734,807 748,920
2025-09-30 $11,358,222 738,266
2025-09-30 $610,784 39,700
2025-06-30 $320,283 34,200
2025-06-30 $99,269 10,600
2025-06-30 $1,568,571 167,493
2025-03-31 $1,132,873 92,216
2025-03-31 $253,071 20,600
2024-12-31 $6,689,320 506,000
2024-12-31 $168,528 12,748
2024-09-30 $762,300 39,600
2024-09-30 $1,124,200 58,400
2024-09-30 $2,570,663 133,541
2024-06-30 $3,147,474 153,311
2024-03-31 $2,701,966 113,528
2023-12-31 $2,313,694 107,066
2023-09-30 $2,179,902 150,131
2023-06-30 $870,374 41,585
2023-03-31 $1,338,732 63,387
2022-12-31 $474,896 18,660
2021-12-31 $476,719 21,778
2021-03-31 $425,577 19,033
2020-12-31 $1,175,295 52,846
2020-06-30 $542,040 36,575
2020-06-30 $370,500 25,000
2020-06-30 $182,286 12,300